GilbeyTMilneBde SomerF, et al.Neurologic complications after cardiopulmonary bypass - a narrative review. Perfusion2023; 38: 1545–1559.
2.
AlstonRP. Pumphead–or not! Does avoiding cardiopulmonary bypass for coronary artery bypass surgery result in less brain damage?Br J Anaesth2005; 94: 699–701.
3.
AlstonRP. Brain damage and cardiopulmonary bypass: is there really any association?Perfusion2011; 26(Suppl 1): 20–26.
4.
KennedyEDChoyKCAlstonRP, et al.Cognitive outcome after on- and off-pump coronary artery bypass grafting surgery: a systematic review and meta-analysis. J Cardiothorac Vasc Anesth2013; 27: 253–265.
5.
BermanMCardoneDSharplesL, et al.Safety and efficacy of aprotinin and tranexamic acid in pulmonary endarterectomy surgery with hypothermia: review of 200 patients. Ann Thorac Surg2010; 90: 1432–1436.
6.
LeckerIWangDSWhissellPD, et al.Tranexamic acid-associated seizures: causes and treatment. Ann Neurol2016; 79: 18–26.
7.
MylesPSSmithJAForbesA, et al.Tranexamic acid in patients undergoing coronary-artery surgery. N Engl J Med2017; 376: 136–148.
8.
MylesPSSmithJAKaszaJ, et al.Tranexamic acid in coronary artery surgery: one-year results of the aspirin and tranexamic acid for coronary artery surgery (ATACAS) trial. J Thorac Cardiovasc Surg2019; 157: 644–652.